Kathleen O’Brien
Fast Adverse-Event Reporting Turnarounds Mean a Translation Challenge
Workloads in pharmacovigilance (PV) are soaring, and with new medicines constantly entering the global market, the need to track adverse events (AE) from drugs is more critical than ever. Regulators’ demands are unrelenting, and reports must be filed within a strict 24-hour window.